Target intelligence / Profile preview

UBE2L3 pseudogene 1 (UBE2L3P1)

Target: UBE2L3P1
Molecular classification: Other, Pseudogene

Overview

UBE2L3 pseudogene 1 (UBE2L3P1) is classified as a pseudogene related to the ubiquitin-conjugating enzyme E2 L3 gene (UBE2L3). Pseudogenes are segments of DNA that resemble protein-coding genes but have lost their protein-coding ability or are otherwise nonfunctional. UBE2L3P1 does not encode an active enzyme and is not known to produce a functional RNA or protein product. Pseudogenes like UBE2L3P1 are typically not therapeutic targets, do not have established biological or disease roles, and are not the subject of drug interactions. This distinguishes them from their corresponding functional genes, such as UBE2L3, which is involved in ubiquitin-mediated protein degradation and has established roles in cellular pathways and disease.

Other names: UBE2L3P1UBE2L3 pseudogene 1

Beyond the preview

Go deeper on UBE2L3 pseudogene 1 (UBE2L3P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on UBE2L3 pseudogene 1 (UBE2L3P1).

Explore the full profile